One Label per Peptide Is Not the Same as One Defined Labeling Site
Separate average labeling degree from positional identity in custom peptide conjugates. Use an attachment map and explicit mixture boundaries before ordering.
Practical write-ups on the parts of peptide sourcing that cause the most back-and-forth: documentation, specifications and supplier communication. Published occasionally rather than on a schedule.
Separate average labeling degree from positional identity in custom peptide conjugates. Use an attachment map and explicit mixture boundaries before ordering.
Ask what separates free dye from the intended fluorescent peptide. Connect purification scope, attachment evidence and the observed signal before accepting a labeled material.
Map P1 and P1-prime positions, labels and intended cleavage observations for a custom peptide substrate. Avoid ambiguous numbering in the synthesis request.
Investigate low peptide recovery without assuming synthesis failure. Map container contact, preparation history and analytical evidence before changing the order.
Distinguish exchangeable deuterium used in HDX studies from a defined isotope-labeled reference. Specify label positions and intended handling conditions clearly.
Define ligation junctions and delivery stages before quoting a long peptide project. Separate reactive fragments, completed material and analytical acceptance scope.
Avoid confusing sequence reversal with stereochemical inversion. Use a simple orientation-and-configuration map to define custom peptide controls clearly.
Specify an N-terminal glutamine or pyroglutamate without ambiguity. Connect the intended structure, comparison material and analytical question in a custom peptide order.
Understand why equal-mass peaks in a proline-containing peptide need investigation. Separate a possible conformational explanation from a verified impurity assignment.
Separate intended Asn, Asp and isoAsp structures from possible changes during preparation. Define the comparison question and evidence before custom peptide synthesis.
Compare immobilized peptide arrays with soluble peptide libraries. Understand orientation, layout and follow-up needs before treating the formats as interchangeable.
Prepare a proteomics peptide request using a protein reference, sequence uniqueness and measurement context. Do not assume a synthetic standard represents every digestion step.
Define the intended cysteine state before a peptide synthesis or conjugation request. A sequence letter does not completely specify free thiol, blocking or disulfide connectivity.
Understand methionine oxidation as a structural change, not a visual diagnosis. Interpret a near +16 Da shift with method scope and avoid silent sequence substitutions.
Understand how a peptoid differs from an N-methylated peptide and a D-peptide. Specify each building block structurally instead of relying on one-letter shorthand.
Specify a branched peptide by its scaffold, arm sequences and attachment map. Learn why one branched molecule is not the same as a mixture of linear peptides.
Define azide or alkyne peptide handles by structure and attachment site. Avoid confusing different click-chemistry meanings or assuming a finished conjugate is included.
Plan a research FRET peptide with explicit donor, acceptor or quencher positions. Distinguish cleavage readouts from guaranteed assay performance before requesting synthesis.
Plan a peptide truncation series with clear boundaries, terminal states and controls. A worked sequence map shows why a shorter fragment needs its own specification.
Design peptide comparisons with explicit scrambled or reversed sequences. Understand what stays constant, what changes and why neither is automatically an inactive control.
Plan a peptide variant series with a frozen parent, explicit changes and independent line IDs. Pilot deliverables and controls should have defined amounts and evidence scope.
Compare crude, desalted and purified peptide proposals using actual processing and analytical deliverables. A quality label alone does not define acceptance or quantity.
Build a multi-chain peptide RFQ with individual chain identities, connection map and assembly scope. Chain count and disulfide count alone do not define the target.
Specify lipidated peptides with fatty-acid identity, linker and residue attachment site. Keep modified-material quantity and structural evidence separate from the parent peptide.
Define PEGylated peptide projects with PEG identity, size description and attachment site. A nominal PEG mass alone does not describe the complete target structure.
Specify peptide–protein conjugation by peptide structure, carrier identity and attachment scope. Keep unconjugated peptide, conjugate amount and analytical evidence distinct.
Choose overlapping or alanine-scanning library design with clear source numbering, member structures and control mapping. Design intent is separate from delivery and purity scope.
Define stable-isotope peptides with the isotope atoms, labeled residues and position map. Ask separately about enrichment, peptide purity and quantitative amount evidence.
Specify phosphopeptides by residue identity, numbering convention and modified positions. Keep unmodified controls and positional variants on separate project lines.
Prepare a difficult-peptide feasibility brief with the exact sequence, fixed features, permitted alternatives and analytical deliverables before accepting a synthesis proposal.
Protect confidential peptide projects by limiting the first inquiry and agreeing a secure exchange route. Clarify recipients, confidentiality terms and version control.
Define custom peptide purity acceptance with method scope, reporting basis and supporting records. Keep identity, quantity and deviation decisions separate from one percentage.
Reconfirm custom peptide identity, quantity basis, analysis, packaging and timing before scaling from mg to g. Treat the larger scope as a reviewed project revision.
Prepare labeled peptide requests with exact label identity, attachment site, linker and assay context. Define control materials and evidence without assuming performance.
Avoid ambiguous custom peptide sequences by identifying D-amino acids and non-standard residues explicitly. Align numbering, structures, termini and version approval.
Define disulfide connectivity as a numbered cysteine-pair map. Separate bond-count or intact-mass observations from evidence that addresses the requested connections.
Specify cyclic peptides with bond type, linked positions, termini and topology. Ask what evidence supports the requested structure before approving synthesis scope.
Prepare a peptide solubility project brief with the intended assay conditions, material form and verification scope. Keep predictions separate from measured acceptance.
Specify peptide counterion requirements separately from sequence and purity. Define the proposed salt, residual-ion reporting and verification scope before requesting synthesis.
Understand peptide synthesis quote scope: sequence, modifications, amount, purification and deliverables. Build a comparable RFQ without relying on per-residue prices.
Use clear decision points so changes do not become mismatches at handover.
Agree what must be reported and how it will be reviewed before a project is quoted.
Make the requested terminal form explicit rather than leaving it hidden in an informal product name.
A clear project brief reduces ambiguity before feasibility and quotation review.
A custom peptide project moves through sequence review, solid-phase synthesis, cleavage, purification, analysis and documentation. This guide describes each stage and the documents you can expect with your order.
What each part of a COA is telling you, which fields have to match your order, and the checks worth doing before you accept a batch.
GLP-1 receptor peptides influence glucose-dependent insulin release and appetite signalling. This note explains how native GLP-1 compares with longer-acting analogues, and what researchers typically confirm before using these peptides.
The line between a peptide and a protein is mostly about size. This article compares short peptides with full-length proteins in structure, function and analysis, and explains what the difference means when you source either type of product.
Peptides are short chains of amino acids that sit between individual amino acids and full-length proteins. This beginner's guide explains what peptides are, how they are named, and why synthetic peptides are widely used in research and formulation.
Share a few details and our team will get back to you.